Healthequity (HQY) Share-based Compensation (2013 - 2026)

Healthequity's Share-based Compensation history runs 14 years deep, the most recent figure standing at $19.4 million for Q2 2026.

• In Q2 2026, Share-based Compensation rose 35.37% year-over-year to $19.4 million; the TTM figure through Apr 2026 stood at $78.1 million (down 0.77% YoY), while the FY2026 annual figure was $73.1 million, down 24.23% from the prior year.
• Share-based Compensation was $19.4 million for Q2 2026 at Healthequity, up from $19.1 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $32.0 million in Q2 2024 to a low of $11.0 million in Q1 2022.
• Historically, Share-based Compensation has averaged $18.9 million across 5 years, with a median of $19.1 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Share-based Compensation jumped 75.9% in 2024, then sank 55.23% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $18.2 million in 2022, then gained by 19.22% to $21.7 million in 2023, then fell by 2.49% to $21.1 million in 2024, then fell by 2.75% to $20.5 million in 2025, then slipped by 5.53% to $19.4 million in 2026.
• The last three Share-based Compensation figures came in at $19.4 million (Q2 2026), $19.1 million (Q1 2026), and $20.5 million (Q4 2025), per Business Quant data.